These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38174435)

  • 1. Comparative analysis of the quality of platelet concentrates produced by apheresis procedures, platelet rich plasma, and buffy coat.
    Li M; Zhao Y; Chen X; Du X; Luo Y; Li Y; Kang J; Wan L; Tang J; Fu X
    Transfusion; 2024 Feb; 64(2):367-379. PubMed ID: 38174435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in levels of platelet-derived microparticles in platelet components prepared using the platelet rich plasma, buffy coat, and apheresis procedures.
    Noulsri E; Udomwinijsilp P; Lerdwana S; Chongkolwatana V; Permpikul P
    Transfus Apher Sci; 2017 Apr; 56(2):135-140. PubMed ID: 28029568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
    Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
    Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A; Kurtz J; Moroff G; Wagner SJ
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods.
    Tynngård N; Lindahl TL; Trinks M; Studer M; Berlin G
    Transfusion; 2008 Apr; 48(4):715-22. PubMed ID: 18208416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assessment of platelet concentrates prepared by platelet-rich plasma, buffy-coat, and apheresis methods in a tertiary care hospital in South India: A cross-sectional study.
    Toora E; Kulkarni RG; Manivannan P; Sastry AS; Basavarajegowda A; Sahoo D
    Asian J Transfus Sci; 2023; 17(2):239-245. PubMed ID: 38274963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
    Ali SF
    Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods.
    Singh RP; Marwaha N; Malhotra P; Dash S
    Asian J Transfus Sci; 2009 Jul; 3(2):86-94. PubMed ID: 20808653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of platelet concentrates prepared after two hours and overnight storage of buffy coat at room temperature.
    Ojha S; Tirlotkar A; Gupta AM; S H S; Chavan P; Poojary M
    Transfus Apher Sci; 2021 Feb; 60(1):103014. PubMed ID: 33262053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro variables of buffy coat-derived platelet concentrates with residual plasma of down to 10% are stably maintained in new-generation platelet additive solutions.
    Gravemann U; Volgmann T; Min K; Philipp R; Lambrecht B; Müller TH; Seltsam A
    Transfusion; 2015 Jul; 55(7):1700-9. PubMed ID: 25677807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet storage lesion in interim platelet unit concentrates: A comparison with buffy-coat and apheresis concentrates.
    Singh S; Shams Hakimi C; Jeppsson A; Hesse C
    Transfus Apher Sci; 2017 Dec; 56(6):870-874. PubMed ID: 29126740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine levels as performance indicators for white blood cell reduction of platelet concentrates.
    Wadhwa M; Krailadsiri P; Dilger P; Gaines Das R; Seghatchian MJ; Thorpe R
    Vox Sang; 2002 Aug; 83(2):125-36. PubMed ID: 12201842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomic analysis of platelets during storage: a comparison between apheresis- and buffy coat-derived platelet concentrates.
    Paglia G; Sigurjónsson ÓE; Rolfsson Ó; Hansen MB; Brynjólfsson S; Gudmundsson S; Palsson BO
    Transfusion; 2015 Feb; 55(2):301-13. PubMed ID: 25156572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system.
    Vetlesen A; Mirlashari MR; Ezligini F; Kjeldsen-Kragh J
    Transfusion; 2007 Jan; 47(1):126-32. PubMed ID: 17207241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of platelet activation and apoptosis in platelet concentrates collected by apheresis.
    Procházková R; Andrýs C; Hubácková L; Krejsek J
    Transfus Apher Sci; 2007 Oct; 37(2):115-23. PubMed ID: 17945536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of simulated shipping conditions (24- or 30-hr interruption of agitation) on the in vitro properties of apheresis platelets during 7-day storage.
    Wagner SJ; Vassallo R; Skripchenko A; Einarson M; Seetharaman S; Moroff G
    Transfusion; 2008 Jun; 48(6):1072-80. PubMed ID: 18373503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volume-reduced platelet concentrates: optimization of production and storage conditions.
    van der Meer PF; Bontekoe IJ; Kruit G; Peeters G; van Toledo PJ; Tomson B; de Korte D
    Transfusion; 2012 Apr; 52(4):819-27. PubMed ID: 21981439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates.
    Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
    Transfusion; 2008 Oct; 48(10):2114-21. PubMed ID: 18647365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
    Vasconcelos E; Figueiredo AC; Seghatchian J
    Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days.
    Albanyan AM; Harrison P; Murphy MF
    Transfusion; 2009 Jan; 49(1):108-17. PubMed ID: 18954396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.